Nano-X Imaging (NNOX) Competitors $4.99 +0.08 (+1.63%) Closing price 07/16/2025 04:00 PM EasternExtended Trading$4.99 0.00 (0.00%) As of 05:12 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock NNOX vs. FNA, TNDM, LQDA, PLSE, BLFS, SSII, MDXG, INMD, SIBN, and KMTSShould you be buying Nano-X Imaging stock or one of its competitors? The main competitors of Nano-X Imaging include Paragon 28 (FNA), Tandem Diabetes Care (TNDM), Liquidia Technologies (LQDA), Pulse Biosciences (PLSE), BioLife Solutions (BLFS), SS Innovations International (SSII), MiMedx Group (MDXG), InMode (INMD), SiBone (SIBN), and Kestra Medical Technologies (KMTS). These companies are all part of the "medical equipment" industry. Nano-X Imaging vs. Its Competitors Paragon 28 Tandem Diabetes Care Liquidia Technologies Pulse Biosciences BioLife Solutions SS Innovations International MiMedx Group InMode SiBone Kestra Medical Technologies Nano-X Imaging (NASDAQ:NNOX) and Paragon 28 (NYSE:FNA) are both small-cap medical equipment companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, risk, earnings, profitability, institutional ownership, media sentiment, valuation and dividends. Which has more volatility & risk, NNOX or FNA? Nano-X Imaging has a beta of 1.96, indicating that its share price is 96% more volatile than the S&P 500. Comparatively, Paragon 28 has a beta of 1.47, indicating that its share price is 47% more volatile than the S&P 500. Which has preferable earnings and valuation, NNOX or FNA? Nano-X Imaging has higher earnings, but lower revenue than Paragon 28. Paragon 28 is trading at a lower price-to-earnings ratio than Nano-X Imaging, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNano-X Imaging$11.28M25.56-$53.52M-$0.90-5.54Paragon 28$256.18M4.29-$57.53M-$0.63-20.80 Do analysts rate NNOX or FNA? Nano-X Imaging currently has a consensus target price of $9.50, indicating a potential upside of 90.38%. Paragon 28 has a consensus target price of $12.75, indicating a potential downside of 2.71%. Given Nano-X Imaging's stronger consensus rating and higher possible upside, research analysts clearly believe Nano-X Imaging is more favorable than Paragon 28.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nano-X Imaging 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 3.25Paragon 28 0 Sell rating(s) 4 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.20 Do insiders and institutionals believe in NNOX or FNA? 21.5% of Nano-X Imaging shares are owned by institutional investors. Comparatively, 63.6% of Paragon 28 shares are owned by institutional investors. 7.7% of Nano-X Imaging shares are owned by company insiders. Comparatively, 15.3% of Paragon 28 shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Is NNOX or FNA more profitable? Paragon 28 has a net margin of -25.31% compared to Nano-X Imaging's net margin of -472.19%. Nano-X Imaging's return on equity of -30.92% beat Paragon 28's return on equity.Company Net Margins Return on Equity Return on Assets Nano-X Imaging-472.19% -30.92% -27.73% Paragon 28 -25.31%-37.90%-18.22% Does the media prefer NNOX or FNA? In the previous week, Nano-X Imaging had 3 more articles in the media than Paragon 28. MarketBeat recorded 3 mentions for Nano-X Imaging and 0 mentions for Paragon 28. Nano-X Imaging's average media sentiment score of 1.49 beat Paragon 28's score of 0.00 indicating that Nano-X Imaging is being referred to more favorably in the media. Company Overall Sentiment Nano-X Imaging Positive Paragon 28 Neutral SummaryNano-X Imaging beats Paragon 28 on 11 of the 17 factors compared between the two stocks. Get Nano-X Imaging News Delivered to You Automatically Sign up to receive the latest news and ratings for NNOX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NNOX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NNOX vs. The Competition Export to ExcelMetricNano-X ImagingTechnology Services IndustryBusiness SectorNASDAQ ExchangeMarket Cap$283.70M$2.43B$15.06B$9.31BDividend YieldN/A1.46%2.76%4.09%P/E Ratio-5.5431.0228.1819.69Price / Sales25.5639.1244.27100.25Price / CashN/A43.7226.2457.53Price / Book1.536.086.445.67Net Income-$53.52M$33.22M$196.70M$257.51M7 Day Performance-3.67%-0.27%-0.05%-0.16%1 Month Performance-1.38%9.70%6.47%9.89%1 Year Performance-41.43%24.51%18.56%15.08% Nano-X Imaging Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NNOXNano-X Imaging2.5165 of 5 stars$4.99+1.6%$9.50+90.4%-47.6%$283.70M$11.28M-5.54190News CoveragePositive NewsAnalyst UpgradeFNAParagon 28N/A$13.11+0.1%$12.75-2.7%+59.8%$1.10B$256.18M-17.71343,000High Trading VolumeTNDMTandem Diabetes Care4.1218 of 5 stars$16.25-3.2%$33.43+105.7%-66.5%$1.08B$940.20M-5.852,650Positive NewsAnalyst RevisionLQDALiquidia Technologies3.2192 of 5 stars$12.45+2.1%$26.89+116.0%+10.6%$1.06B$14M-7.8850Trending NewsInsider TradePLSEPulse Biosciences3.7362 of 5 stars$15.81+3.3%$22.00+39.2%-18.5%$1.06B$700K0.00140BLFSBioLife Solutions2.0157 of 5 stars$21.81-4.5%$31.17+42.9%-7.6%$1.04B$82.25M-75.20440Positive NewsSSIISS Innovations InternationalN/A$5.27-1.3%N/AN/A$1.02B$22.13M0.004MDXGMiMedx Group3.7084 of 5 stars$6.48+2.2%$12.50+92.9%-10.3%$957.11M$352.38M24.00870News CoverageAnalyst ForecastINMDInMode4.0933 of 5 stars$15.10-0.4%$18.54+22.8%-25.2%$954.47M$394.82M6.48480Positive NewsSIBNSiBone3.9826 of 5 stars$18.02-2.4%$22.50+24.9%+0.8%$768.01M$167.18M-28.16350Positive NewsKMTSKestra Medical TechnologiesN/A$14.75-5.9%$27.50+86.4%N/A$757.41MN/A0.00300High Trading Volume Related Companies and Tools Related Companies Paragon 28 Competitors Tandem Diabetes Care Competitors Liquidia Technologies Competitors Pulse Biosciences Competitors BioLife Solutions Competitors SS Innovations International Competitors MiMedx Group Competitors InMode Competitors SiBone Competitors Kestra Medical Technologies Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NNOX) was last updated on 7/17/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nano-X Imaging Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nano-X Imaging With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.